SUMOylation of ZFP282 potentiates its positive effect on estrogen signaling in breast tumorigenesis

Oncogene. 2013 Aug 29;32(35):4160-8. doi: 10.1038/onc.2012.420. Epub 2012 Sep 17.

Abstract

Estrogen receptor α (ERα) has critical roles in the development and progression of breast cancer, and the coiled-coil co-activator (CoCoA) is an important ERα co-activator for estrogen-induced gene expression. The small ubiquitin-like modifier (SUMO) pathway is hyperactivated in breast cancer, but the mechanism by which SUMOylation regulates ERα-mediated transcription remains poorly understood. Here, we identified ZFP282 as a CoCoA-binding protein. ZFP282 associates directly with ERα and cooperates synergistically with CoCoA to enhance ERα function. ZFP282 is required for estrogen-induced expression of ERα target genes and estrogen-dependent breast cancer cell growth and tumorigenesis. In addition, we found that ZFP282 is SUMOylated and that SUMOylation positively regulates the co-activator activity of ZFP282 by increasing its binding affinity to ERα and CoCoA, and consequently increasing recruitment of ZFP282-CoCoA complex to the promoter of ERα target genes. These findings reveal essential roles for ZFP282 and its SUMOylation in estrogen signaling and breast tumorigenesis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms / etiology*
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Estrogen Receptor alpha / physiology*
  • Female
  • Human T-lymphotropic virus 1 / genetics
  • Humans
  • Signal Transduction / physiology*
  • Sumoylation*
  • Terminal Repeat Sequences
  • Transcription, Genetic
  • Zinc Fingers*

Substances

  • ESR1 protein, human
  • Estrogen Receptor alpha